logo

For the Inventor, By the Inventor

Atlanta, GA, United States of America

Jack Arbiser

This inventor holds 24 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents, primarily in Cancer Treatment. Top assignees: Emory University, The United States Government as Represented by the Department of Veterans Affairs, Children's Healthcare of Atlanta, Inc.. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jack Arbiser. Retrieved from https://idiyas.com/inventor/jack-arbiser

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 70.8


Average Co-Inventor Count = 1.4

ph-index = 5

Forward Citations = 108(Granted Patents)


Company Filing History:

goldMedal14 out of 1,024 
 
Emory University
 patents
silverMedal5 out of 958 
 
The United States Government as Represented by the Department of Veterans Affairs
 patents
bronzeMedal2 out of 87 
 
Children's Healthcare of Atlanta, Inc.
 patents
4. 2 out of 2,193 
 
Georgia Tech Research Corporation
 patents
5. 1 out of 5 
 
Mercer University
 patents
6. 1 out of 1 
 
Natuderm, LLC
 patent
7. 1 out of 1 
 
U.S. Government as Represented by the Dept. of Va
 patent
8. 1 out of 3 
 
Union University
 patents
9. 10 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Palladium
Hyaluronic Acid
Nanocarrier Therapy
Proteasome Inhibitors
Angiogenesis
Curcumin
Chalcone
Cancer
Solenopsin
Triarylmethane
Dermatological Treatments
Combination Therapy
24 patents (USPTO):Explore Patents
1. 12233087 - Palladium hyaluronic acid particles and methods of managing cancer or angiogenic conditions (2025-02-25),
2. 10792274 - Dehydroacetic acid (DHAA) and derivative for uses in treating cancer (2020-10-06),
3. 10376522 - Triarylmethane analogs and their use in treating cancers (2019-08-13),
4. 9872834 - Nanocarrier therapy for treating invasive tumors (2018-01-23),
5. 9592226 - Solenopsin and derivatives, therapeutic compositions; and methods related thereto (2017-03-14),
6. 9567291 - N-(4-(bis(4-(dimethylamino)phenyl)methylene)-8-(dimethylamino) (2017-02-14),
7. 9358226 - Triarylmethane analogs and their use in treating cancers (2016-06-07),
8. 9289414 - Carbazole formulations for the treatment of psoriasis and angiogenesis (2016-03-22),
9. 9220682 - Nanocarrier therapy for treating invasive tumors (2015-12-29),
10. 8889744 - Bis-trifluoromethyl honokiol analogs and their use in treating cancers (2014-11-18),
11. 8841276 - Fulvene and fulvalene analogs and their use in treating cancers (2014-09-23),
12. 8822531 - Honokiol analogs and their use in treating cancers (2014-09-02),
13. 8809283 - Proteasome inhibitors and uses thereof (2014-08-19),
14. 8691777 - Combination therapy (2014-04-08),
15. 8586627 - Honokiol analogs and their use in treating cancers (2013-11-19),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I focus on those specific themes. If you have any requests within these topics, feel free to let me know!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…